Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,600
Avg Vol 5,460
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 2%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. It operates in Canada, the United States, Australia, and the European Union. ZYUS Life Sciences Corporati...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 888 651 9987
Address:
Unit 204, 407 Downey Road, Saskatoon, Canada
Robbere
Robbere Jun. 4 at 12:00 PM
$ZLSCF https://www.businesswire.com/news/home/20240604190441/en/ZYUS-Life-Sciences-Receives-Cannabis-Drug-License-from-Health-Canada
1 · Reply
Vetiver
Vetiver Apr. 17 at 4:46 PM
$ZLSCF => $ZYUS.V company founded 5 years ago by Brent Zettl! https://www.zyus.com/about-us/leadership-team/default.aspx #pharma #Phase2 #bio
0 · Reply
Latest News on ZLSCF
No data available.
Robbere
Robbere Jun. 4 at 12:00 PM
$ZLSCF https://www.businesswire.com/news/home/20240604190441/en/ZYUS-Life-Sciences-Receives-Cannabis-Drug-License-from-Health-Canada
1 · Reply
Vetiver
Vetiver Apr. 17 at 4:46 PM
$ZLSCF => $ZYUS.V company founded 5 years ago by Brent Zettl! https://www.zyus.com/about-us/leadership-team/default.aspx #pharma #Phase2 #bio
0 · Reply